Mindfulness-Art Therapy Intervention in Abused Adolescents
Effectiveness of the Mindfulness and Art Therapy Group Program on Body Self-Concept and Shame in Adolescents With a History of Abuse
Adolescence is an important stage of development when many mental health difficulties first appear. Young people who have experienced abuse are especially vulnerable, as abuse can lead to intense feelings of shame and negatively affect their body self-concept. This study explored whether a group program combining mindfulness and art therapy-called the Mindfulness and Art Therapy Group Program (MATG-P)-could help adolescents with a history of abuse. Mindfulness helps young people become more aware of their thoughts and feelings in a nonjudgmental way, while art therapy allows them to express emotions safely and creatively. Although both approaches have been used separately, their combined effect was not previously studied among vulnerable adolescents. . Therefore, this study aimed to investigate the effectiveness of the Mindfulness and Art Therapy Group Program on body self-concept and shame in adolescents with a history of abuse.
After completing the intervention and analyzing the data, it was concluded that adolescents who participated in the program showed significant improvements in how they viewed their bodies and experienced lower levels of shame compared to those who did not receive the intervention. These findings suggest that combining mindfulness and art therapy in a group setting may be an effective way to support adolescents who have experienced abuse. Overall, this study highlights the potential contribution of MATG P as a supportive intervention to improve body self-concept and reduce shame among adolescents with a history of abuse.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Tipo de estudio
Tipo de estudio
Inscripción (Actual)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Isfahan, Irán
- Children and Adolescent Care Center, Isfahan Welfare Organization
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Having a history of abuse
- sufficient physical and cognitive ability to participate in the intervention
Exclusion Criteria:
- Having intellectual disability, developmental delay, visual or sensory motor impairments
- a diagnosed psychiatric disorder recorded in the Child Welfare Organization's files
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Experimental: MATG-P
The experimental group received 8 sessions of Mindfulness and Art Therapy Group Program (MATG-P), each lasting 45-60 minutes.
|
Each session of MATG-P included three components: a meditation practice of 10 to 15 minutes, a reflective art activity of 20 to 30 minutes, and a therapeutic discussion of about 15 minutes.
Session's themes followed the original curriculum, beginning with body and breath awareness in the first three weeks.
Emotional awareness was emphasized in weeks four and five, where pleasant, unpleasant, and neutral feelings were explored.
Week six focused on awareness of awareness of attitudes, while weeks seven and eight were dedicated to values and loving kindness practices.
Caregiver-child meetings were designed in the first and last weeks, during which adolescents guided their caregivers in meditation, thereby reinforcing mindfulness and art practices beyond the intervention sessions.
|
|
Sin intervención: control group
Adolescents allocated to the control group did not receive any intervention during the study period.
Adolescents in the control group were placed on a waiting list and, if still residing at the center, were offered the intervention after the study finished.
They continued with their routine activities and the services provided by the Welfare Organization, but no structured therapeutic program was delivered to them.
To minimize attention effect, the control group engaged in brief, non-therapeutic sessions designed to control for attention without incorporating the specific techniques of MATG P.
These sessions consisted of neutral, informational discussions while avoiding any direct engagement in mindfulness-based techniques or art therapy.
This design enabled a direct comparison between adolescents who received MATG P and the control g
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Body self-concept
Periodo de tiempo: Baseline: 1 day before the first intervention session Post-test: 1 day after the final intervention session
|
Body self-concept is a central dimension of self-concept, which includes the thoughts, beliefs, emotions, and behaviors associated with the perceived body and is experienced more as a feeling rather than explicit verbal descriptions.
It was measured using the Piers-Harris Children's Self-Concept Scale (PHCSCS).
Scores range from 0 to 80. Higher scores indicate a more positive body self-concept.
|
Baseline: 1 day before the first intervention session Post-test: 1 day after the final intervention session
|
|
shame
Periodo de tiempo: Baseline: 1 day before the first intervention session Post-test: 1 day after the final intervention session
|
Shame is a self-conscious emotion characterized by negative evaluations of the self, feelings of worthlessness, inferiority, and self-devaluation.
It was measured using the Guilt and Shame Experience Scale (GSES).
Scores range from 8 to 32, with higher scores indicating greater experiences of shame.
|
Baseline: 1 day before the first intervention session Post-test: 1 day after the final intervention session
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Actual)
Finalización primaria
Finalización del estudio (Actual)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- IR.ARDAKAN.REC.1405.013
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .